Sanofi Pasteur readies pipeline of 11 vaccines for RSV, hepatitis A, herpes

Sanofi had acquired Shantha Biotechnics in 2009, which makes vaccines for the company in India

Sanofi Pasteur India is working to manufacture 11 vaccines, some of which may come to India soon. The vaccines player, which accounts for 50 per cent of the doses of the inactivated polio vaccine (IPV) administered to children in India, feels that if optional vaccines such as flu shots are included in large scale public programmes like Ayushman Bharat, it would lead to faster adoption of adult vaccines in India. 

The pipeline includes vaccines for respiratory syndrome virus (RSV), hepatitis A, herpes, new generation meningitis vaccine, a couple of new flu vaccines (targeted for elderly patients), a hexavalent vaccine (Shan6),